Literature DB >> 3827520

Tricyclic antidepressants in depressed patients with cardiac conduction disease.

S P Roose, A H Glassman, E G Giardina, B T Walsh, S Woodring, J T Bigger.   

Abstract

The observation that fatalities from tricyclic antidepressant (TCA) overdose are associated with heart block and/or arrhythmias has led to concern about the cardiovascular effects of TCAs. Contrary to expectations, studies have shown TCAs to be relatively safe in patients without heart disease. However, it is unclear whether these drugs are also safe in patients with heart disease. This prospective study compared the risk of cardiovascular complication at therapeutic plasma concentrations of TCAs in 196 depressed patients, 155 with normal electrocardiograms and 41 with either prolonged PR interval and/or bundle-branch block. The prevalence of second-degree atrioventricular block was significantly greater in patients with preexisting bundle-branch block (9%) than in patients with normal electrocardiograms (0.7%). Orthostatic hypotension occurred significantly more frequently with imipramine than with nortriptyline, and in patients with heart disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3827520     DOI: 10.1001/archpsyc.1987.01800150093011

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  16 in total

Review 1.  The safety of antidepressants.

Authors:  F de Jonghe; J A Swinkels
Journal:  Drugs       Date:  1992       Impact factor: 9.546

2.  Cardiovascular effects of paroxetine.

Authors:  H Kuhs; G A Rudolf
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 3.  Depression in the elderly: the role of the primary care physician in management.

Authors:  J F McGreevey; K Franco
Journal:  J Gen Intern Med       Date:  1988 Sep-Oct       Impact factor: 5.128

Review 4.  Depression and ischemic heart disease: overview of the evidence and treatment implications.

Authors:  Wei Jiang; James A Blumenthal
Journal:  Curr Psychiatry Rep       Date:  2003-05       Impact factor: 5.285

Review 5.  Selective serotonin reuptake inhibitors in older patients. A tolerability perspective.

Authors:  U Skerritt; R Evans; S A Montgomery
Journal:  Drugs Aging       Date:  1997-03       Impact factor: 3.923

6.  Late life depression: undertreated?

Authors:  B Baldwin
Journal:  Br Med J (Clin Res Ed)       Date:  1988-02-20

7.  Falls prevention in primary care.

Authors:  Linda Nazarko
Journal:  London J Prim Care (Abingdon)       Date:  2009

Review 8.  Psychopharmacological Treatment in Older People: Avoiding Drug Interactions and Polypharmacy.

Authors:  Torsten Kratz; Albert Diefenbacher
Journal:  Dtsch Arztebl Int       Date:  2019-07-22       Impact factor: 5.594

Review 9.  Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?

Authors:  Pal Pacher; Valeria Kecskemeti
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

Review 10.  Depression and its treatment in cardiac patients.

Authors:  F Fernandez
Journal:  Tex Heart Inst J       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.